Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03932331
Brief Title: Study of Acalabrutinib in Chinese Adult Subjects With Relapsed or Refractory Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia or Other B-cell Malignancies

First Submitted : April 16, 2019
First Submitted that Met QC Criteria : April 29, 2019
First Posted : April 30, 2019

Last Update Submitted that Met QC Criteria : June 17, 2021
Last Update Posted : June 18, 2021